机构:[1]Renmin Univ China, Key Lab DEKE, Beijing, Peoples R China[2]Visionary Intelligence Ltd, Vistel AI Lab, Beijing, Peoples R China[3]Peking Union Med Coll Hosp, Beijing, Peoples R China[4]Beijing Tongren Hosp, Beijing, Peoples R China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[5]Tianjin Medicial Univ, Eye Hosp, Tianjin, Peoples R China[6]China Japanese Riendship Hosp, Beijing, Peoples R China[7]Qingdao Univ, Affilliated Yantai Yuhuangding Hosp, Yantai, Peoples R China
Towards automated retinal screening, this paper makes an endeavor to simultaneously achieve pixel-level retinal lesion segmentation and image-level disease classification. Such a multi-task approach is crucial for accurate and clinically interpretable disease diagnosis. Prior art is insufficient due to three challenges, i.e., lesions lacking objective boundaries, clinical importance of lesions irrelevant to their size, and the lack of one-to-one correspondence between lesion and disease classes. This paper attacks the three challenges in the context of diabetic retinopathy (DR) grading. We propose Lesion-Net, a new variant of fully convolutional networks, with its expansive path redesigned to tackle the first challenge. A dual Dice loss that leverages both semantic segmentation and image classification losses is introduced to resolve the second challenge. Lastly, we build a multi-task network that employs Lesion-Net as a side-attention branch for both DR grading and result interpretation. A set of 12K fundus images is manually segmented by 45 ophthalmologists for 8 DR-related lesions, resulting in 290K manual segments in total. Extensive experiments on this large-scale dataset show that our proposed approach surpasses the prior art for multiple tasks including lesion segmentation, lesion classification and DR grading.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61672523]; Beijing Natural Science FoundationBeijing Natural Science Foundation [4202033]; Beijing Natural Science Foundation Haidian Original Innovation Joint FundBeijing Natural Science Foundation [19L2062]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2018PT32029]; CAMS Initiative for Innovative Medicine (CAMS-I2M) [2018I2M-AI-001]; Pharmaceutical Collaborative Innovation Research Project of Beijing Science and Technology Commission [Z191100007719002]
语种:
外文
被引次数:
WOS:
第一作者:
第一作者机构:[1]Renmin Univ China, Key Lab DEKE, Beijing, Peoples R China[2]Visionary Intelligence Ltd, Vistel AI Lab, Beijing, Peoples R China
通讯作者:
通讯机构:[1]Renmin Univ China, Key Lab DEKE, Beijing, Peoples R China[2]Visionary Intelligence Ltd, Vistel AI Lab, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Wei Qijie,Li Xirong,Yu Weihong,et al.Learn to Segment Retinal Lesions and Beyond[J].2020 25TH INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION (ICPR).2021,7403-7410.doi:10.1109/ICPR48806.2021.9412088.
APA:
Wei, Qijie,Li, Xirong,Yu, Weihong,Zhang, Xiao,Zhang, Yongpeng...&Chen, Youxin.(2021).Learn to Segment Retinal Lesions and Beyond.2020 25TH INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION (ICPR),,
MLA:
Wei, Qijie,et al."Learn to Segment Retinal Lesions and Beyond".2020 25TH INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION (ICPR) .(2021):7403-7410